Peer & Trend Comparison Gross Margin % Before IFRS Voodoo

I will take a one day break from posting the Income Statement Driver and Implied Breakeven charts to post this new one on Peer & Trend Gross Margin. OGI sure has a pretty trend. I will start using the above in quarterly Rundowns.

Continue Reading
ACB Q2 F2019 Rundown Dec. 31, 2018

Firstly, this has taken a little more time as the addition of Rec has added lots of new data to play with.  Usually new data takes me a couple of Q’s to get comfortable with. So bear with me as I try out some new things. Secondly, having scanned Twitter and Reddit I find it interesting the reactions that we are seeing.  These LP’s are oil tankers NOT Zodiacs.  You couple that with the absolute Gong Show that rec roll out has been in the majority of the provinces, sprinkle in the fact that no LP seemingly gets their HC licenses when they think…

Continue Reading
Aurora Cannabis Q1 F2019 Rundown

Open the financial statements and MDA and follow along. I said this last rundown for ACB…. "As a generalization…. If you take two firms with negative Adj EBITDA and you combine them the first Q will never look pretty [See Canopy-Mettrum].  You might get sales boost and other improvements, but to squeeze out synergies takes more than the first Q.  You throw in a huge ramp of Selling expenses and G&A to Day 1 of rec… and these results shouldn’t be too shocking [Illumination series was a cost with future benefit derived later]. I’d expect a similar theme next Q as they absorb MedReleaf."…

Continue Reading
Aurora Cannabis Q4 F2018 Rundown

Open up the fins and the MDA and follow along.First off.. BIG thanks t Glen their CFO for having the courtesy to provide QoQ narrative on OPEX versus YoY comparisons. You have heard me grumble on how useless YoY comparisons are in a fast growing industry like this, so to provide colour is appreciated. Also… they let TheCannalysts ask a couple of Q’s. How about that!So let’s dig in…As a generalization…. If you take two firms with negative Adj EBITDA and you combine them the first Q will never look pretty [See Canopy-Mettrum]. You might get sales boost and other improvements, but to squeeze…

Continue Reading
Aurora Cannabis Q3 F2018 Rundown

Ok… pull up the financial statements and the MDA to follow along.Sales increased $4,400 to $16,100 or 38%$1,072 for Cannabis Sales to a total of $10,813 an 11% increase QoQ$554 Cdn Cannabis up 9% +$670 oil up 44% -$152 European Cannabis Sales down 6% [quite surprised that this dropped given new sales to Italy. I have heard rumours of German product not clearing customs, this net decrease might be an manifestation of that]$2,979 Construction Revenue [Larssen] – New revenue Category +$349 Service Revenue to a total of $2,308 an 18% QoQ increaseOf Note: ACB reduced their reliance on Other LP Sales for the Q,…

Continue Reading
  • 1
  • 2
Close Menu